Literature DB >> 8144627

cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin.

I Eriksson1, D Sandbäck, B Ek, U Lindahl, L Kjellén.   

Abstract

A 110-kDa protein involved in heparin biosynthesis in mouse mastocytoma cells was previously shown to express both glucosaminyl N-deacetylase and N-sulfotransferase activity. In this study, the complete nucleotide sequence corresponding to this protein is reported. The mRNA, estimated to contain 3.9 kilobases encodes a protein with an M(r) of 101,092. The predicted domain structure of the protein resembles those of previously characterized Golgi proteins with an N-terminal cytoplasmic tail, a single membrane-spanning domain, and a large catalytic domain linked to the transmembrane domain through a "stem region." Comparison of the deduced amino acid sequence of the mouse mastocytoma protein and a previously cloned similar enzyme from rat liver demonstrated that while large portions of the proteins, corresponding essentially to the putative catalytic domains, were closely related, other portions, in particular in the N-terminal parts, were markedly different. The divergence was not due to species differences since two separate mouse transcripts could be identified that hybridized with probes specific for the two proteins. Also, functional differences were noted since the mastocytoma enzyme, contrary to the liver enzyme, requires a polycation cofactor for expression of N-deacetylase activity. The results are discussed in relation to the structural properties of heparin and heparan sulfate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144627

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.

Authors:  C McCormick; G Duncan; K T Goutsos; F Tufaro
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  cDNA cloning, genomic organization and chromosomal localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase-2.

Authors:  D E Humphries; J Lanciotti; J B Karlinsky
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

3.  Localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase to the trans-Golgi network.

Authors:  D E Humphries; B M Sullivan; M D Aleixo; J L Stow
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 4.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 5.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

6.  Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle.

Authors:  J Pablo Abonia; Daniel S Friend; William G Austen; Francis D Moore; Michael C Carroll; Rodney Chan; Jalil Afnan; Alison Humbles; Craig Gerard; Pamela Knight; Yoshihide Kanaoka; Shinsuke Yasuda; Nasa Morokawa; K Frank Austen; Richard L Stevens; Michael F Gurish
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

7.  Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases.

Authors:  T Yabe; D Shukla; P G Spear; R D Rosenberg; P H Seeberger; N W Shworak
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

8.  Expression of heparan sulphate L-iduronyl 2-O-sulphotransferase in human kidney 293 cells results in increased D-glucuronyl 2-O-sulphation.

Authors:  J Rong; H Habuchi; K Kimata; U Lindahl; M Kusche-Gullberg
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

9.  'Heparin'--from anticoagulant drug into the new biology.

Authors:  U Lindahl
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

10.  Characterization of cDNA for murine tripeptidyl-peptidase II reveals alternative splicing.

Authors:  B Tomkinson
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.